JPRN-UMIN000006556已完成未知
Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia in patients with schizophrenia, Reserch for efficacy and tolerability. - Adjunctive treatment with pramipexole for antipsychotic-induced hyperprolactinemia.
Department of Neuropsychiatry,University of Fukui0 个研究点目标入组 20 人开始时间: 2011年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •subjects were excluded if they had problems with thyroid function, renal function,liver function, gynecological problems, or other general illnesses.
研究者
相似试验
招募中
1 期
Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOMajor depressionMedDRA version: 20.0Level: PTClassification code: 10002511Term: Anhedonia Class: 100000004873CTIS2024-512495-35-00Region Skane140
招募中
2 期
Efficacy of pramipexole treatment and methylphenidate for attention deficit hyperactivity disorderattention deficit hyperactivity disorder.Disturbance of activity and attentionIRCT20100520003979N7Ahvaz University of Medical Sciences10
已完成
2 期
Efficacy of pramipexole treatment and methylphenidate in children with attention deficit hyperactivity disorder, compared with placebo and methylphenidate.IRCT201612253979N6Research Devision, Ahvaz Jondishapoor Medical University10
招募中
3 期
Adjuvant treatment with Pramipexole for anhedonia symptoms in depression - PRIME-PRAXOL2024-512495-35-00Region Skane140
尚未招募
早期 1 期
Pramipexole and relapse of stimulants abuseIRCT20190315043060N1Kerman University of Medical Sciences100